Related Experiment Video
Updated: Dec 21, 2025
04:32
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
12.3K
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
1International Journal of Pharmaceutical Compounding. lallen@ijpc.com.
International Journal of Pharmaceutical Compounding
|May 14, 2020
Summary
Compounding intravenous admixtures demands understanding drug stability and compatibility, including excipients. This article details preventing and detecting particulate matter in these critical drug preparations.
Area of Science:
- Clinical Pharmaceutics
- Intravenous Admixture Compounding
Background:
- Intravenous admixture compounding necessitates a thorough understanding of stability, compatibility, and incompatibility factors.
- Evaluation of intravenous admixtures must consider both active pharmaceutical ingredients and excipients, which can vary between manufacturers.
- Excipient variations can significantly impact drug compatibility and stability in compounded preparations.
Purpose of the Study:
- To highlight the importance of clinical pharmaceutics in evaluating intravenous admixtures.
- To discuss the critical role of preventing or minimizing particulate matter in intravenous admixture preparation.
- To provide insights into the sources, prevention, and detection methods for particulates in intravenous admixtures.
Main Methods:
- Review of scientific literature on intravenous admixture compounding.
- Analysis of factors influencing drug stability and compatibility.
- Discussion of methods for particulate matter prevention and detection.
Main Results:
- Manufacturer variations in excipients can affect drug compatibility and stability.
- Particulate matter is a critical concern in the preparation of intravenous admixtures.
- Effective strategies exist for preventing and detecting particulate contamination.
Conclusions:
- Comprehensive knowledge of formulation components is essential for safe intravenous admixture compounding.
- Minimizing particulate matter is a key objective for ensuring the quality and safety of intravenous admixtures.
- Clinical pharmaceutics provides a framework for addressing these compounding challenges.
Related Concept Videos
01:30Cleaning, Sterilization, and Disinfection
9.4K
Cleaning, disinfection, and sterilization are the methods that help to break the infection chain and prevent disease.
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
9.4K
01:25Transmission-based Precautions II: Airborne and Protective Environment
1.8K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
586
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
586